Mast cell tumor laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
:*Elevated plasma tryptase levels | :*Elevated plasma tryptase levels | ||
*Plasma and urinary [[histamine]] | *Plasma and urinary [[histamine]] | ||
:*Chronically elevated plasma and urinary histamine levels and its metabolite | :*Chronically elevated plasma and urinary histamine levels and its metabolite N-methylhistamine | ||
*[[Partial thromboplastin time]] | *[[Partial thromboplastin time]] | ||
:*Elevated in a blood sample obtained immediately after attack | :*Elevated in a blood sample obtained immediately after attack | ||
Revision as of 14:55, 2 March 2016
|
Mast cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell tumor laboratory findings On the Web |
|
American Roentgen Ray Society Images of Mast cell tumor laboratory findings |
|
Risk calculators and risk factors for Mast cell tumor laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
The diagnosis of systemic mastocytosis is established by demonstrating mast cell infiltration in an involved tissue, particularly the bone marrow, using special staining techniques or flow cytometry, but the measurement of serum tryptase is a good screening test, since almost all patients with systemic mastocytosis have serum tryptase levels exceeding 20 ng/mL.[1]
- Tryptase levels
- Elevated plasma tryptase levels
- Plasma and urinary histamine
- Chronically elevated plasma and urinary histamine levels and its metabolite N-methylhistamine
- Elevated in a blood sample obtained immediately after attack
References
- ↑ Koenig, Martial; Morel, Jérôme; Reynaud, Jacqueline; Varvat, Cécile; Cathébras, Pascal (2008). "An unusual cause of spontaneous bleeding in the intensive care unit – mastocytosis: a case report". Cases Journal. 1 (1): 100. doi:10.1186/1757-1626-1-100. ISSN 1757-1626.